A systematic experimental evaluation of microRNA markers of human bladder cancer

Frontiers in Genetics

Volumn 4, Issue NOV, 2013, Pages

  Zabolotneva, Anastasia A ^a,b,c   Zhavoronkov, Alex A ^b,c   Shegay, Peter V ^d   Gaifullin, Nurshat M ^e   Alekseev, Boris Y ^d   Roumiantsev, Sergey A ^b   Garazha, Andrew V ^a,b,c   Kovalchuk, Olga ^f   Aravin, Alexey ^g   Buzdin, Anton A ^a,b,c  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b Clinical Center of Pediatric Hematology Oncology and Immunology   (Russian Federation)

^c First Oncology Research and Advisory Centre   (Russian Federation)

^d P A Herzen Research Oncological Institute   (Russian Federation)

^e LOMONOSOV MOSCOW STATE UNIVERSITY   (Russian Federation)

^f UNIVERSITY OF LETHBRIDGE   (Canada)

^g California Institute of Technology   (United States)

Author keywords

Bladder cancer; Intracellular regulatory pathways; microRNA; Molecular markers; Transcriptome analysis

Indexed keywords

EID: 84890307146     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00247     Document Type: Article

References (51)

1. Adachi, R., Horiuchi, S., Sakurazawa, Y., Hasegawa, T., Sato, K., and Sakamaki, T. (2011). ErbB2 down-regulates microRNA-205 in breast cancer. Biochem. Biophys. Res. Commun. 411, 804-808. doi: 10.1016/j.bbrc.2011.07.033.
2. Aravin, A. A., Sachidanandam, R., Bourc'his, D., Schaefer, C., Pezic, D., Toth, K. F., et al. (2008). A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice. Mol. Cell 31, 785-799. doi: 10.1016/j.molcel.2008.09.003.
3. Baskaev, K., Garazha, A., Gaifullin, N., Suntsova, M. V., Zabolotneva, A. A., and Buzdin, A. A. (2012). nMETR: technique for facile recovery of hypomethylation genomic tags. Gene 498, 75-80. doi: 10.1016/j.gene.2012.01.097.
4. Bhatnagar, N., Li, X., Padi, S. K., Zhang, Q., Tang, M. S., and, Guo, B. (2010). Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis. 1:e105. doi: 10.1038/cddis.2010.85.
5. Billerey, C., Chopin, D., Aubriot-Lorton, M. H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., et al. (2001). Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am. J. Pathol. 158, 1955-1959. doi: 10.1016/S0002-9440(10)64665-2.
6. Blobe, G., Schiemann, W., and Lodish, H. (2000). Role of transforming growth factor (beta) in human disease. N. Engl. J. Med. 343, 228. doi: 10.1056/NEJM200005043421807.
7. Boyd, S. D. (2008). Everything you wanted to know about small RNA but were afraid to ask. Lab. Invest. 88, 569-578. doi: 10.1038/labinvest.2008.32.
8. Brennecke, J., Aravin, A. A., Stark, A., Dus, M., Kellis, M., Sachidanandam, R., et al. (2007). Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell 128, 1089-1103. doi: 10.1016/j.cell.2007.01.043.
9. Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 101, 2999-3004. doi: 10.1073/pnas.0307323101.
10. Castillo-Martin, M., Domingo-Domenech, J., Karni-Schmidt, O., Matos, T., and Cordon-Cardo, C. (2010). Molecular pathways of urothelial development and bladder tumorigenesis. Urol. Oncol. 28, 401-408. doi: 10.1016/j.urolonc.2009.04.019.
11. Catto, J. W., Miah, S., Owen, H. C., Bryant, H., Myers, K., Dudziec, E., et al. (2009). Distinct microRNA alterations characterize high-and low-grade bladder cancer. Cancer Res. 69, 8472-8481. doi: 10.1158/0008-5472.CAN-09-0744.
12. Chen, F., and Hu, S. J. (2012). Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. J. Biochem. Mol. Toxicol. 26, 79-86. doi: 10.1002/jbt.20412.
13. Diatchenko, L., Lau, Y. F., Campbell, A. P., Chenchik, A., Moqadam, F., Huang, B., et al. (1996). Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. U.S.A. 93, 6025-6030. doi: 10.1073/pnas.93.12.6025.
14. Dyrskjot, L., Ostenfeld, M. S., Bramsen, J. B., Silahtaroglu, A. N., Lamy, P., Ramanathan, R., et al. (2009). Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 69, 4851-4860. doi: 10.1158/0008-5472.CAN-08-4043.
15. Eddy, S. R. (2001). Non-coding RNA genes and the modern RNA world. Nat. Rev. Genet. 2, 919-929. doi: 10.1038/35103511.
16. Fendler, A., Stephan, C., Yousef, G. M., and Jung, K. (2011). MicroRNAs as regulators of signal transduction in urological tumors. Clin. Chem. 57, 954-968. doi: 10.1373/clinchem.2010.157727.
17. Golka, K., Selinski, S., Lehmann, M. L., Blaszkewicz, M., Marchan, R., Ickstadt, K., et al. (2011). Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs." Arch. Toxicol. 85, 539-554. doi: 10.1007/s00204-011-0676-3.
18. Gordon, K. J., and, Blobe, G. C. (2008). Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim. Biophys. Acta 1782, 197-228. doi: 10.1016/j.bbadis.2008.01.006.
19. Gottardo, F., Liu, C. G., Ferracin, M., Calin, G. A., Fassan, M., Bassi, P., et al. (2007). Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 25, 387-392. doi: 10.1016/j.urolonc.2007.01.019.
20. Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., and Enright, A. J. (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140-D144. doi: 10.1093/nar/gkj112.
21. Han, Y., Chen, J., Zhao, X., Liang, C., Wang, Y., Sun, L., et al. (2011). MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS ONE 6:e18286. doi: 10.1371/journal.pone.0018286.
22. Hannon, G. J. (2002). RNA interference. Nature 418, 244-251. doi: 10.1038/418244a.
23. Hoglund, M. (2012). The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles. Urol. Oncol. 30, 533-540. doi: 10.1016/j.urolonc.2012.04.001.
24. Hurd, P. J., and, Nelson, C. J. (2009). Advantages of next-generation sequencing versus the microarray in epigenetic research. Brief. Funct. Genomic. Proteomic. 8, 174-183. doi: 10.1093/bfgp/elp013.
25. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2008). Global cancer statistics. CA. Cancer J. Clin. 61, 69-90. doi: 10.3322/caac.20107.
26. Jung, M., Schaefer, A., Steiner, I., Kempkensteffen, C., Stephan, C., Erbersdobler, A., et al. (2010). Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin. Chem. 56, 998-1006. doi: 10.1373/clinchem.2009.141580.
27. Kent, O. A., Chivukula, R. R., Mullendore, M., Wentzel, E. A., Feldmann, G., Lee, K. H., et al. (2010). Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev. 24, 2754-2759. doi: 10.1101/gad.1950610.
28. Kim, W. J., and Kim, Y. J. (2012). Epigenetics of bladder cancer. Methods Mol. Biol. 863, 111-118. doi: 10.1007/978-1-61779-612-8_6.
29. Kimura, S., Naganuma, S., Susuki, D., Hirono, Y., Yamaguchi, A., Fujieda, S., et al. (2010). Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol. Rep. 23, 1625-1633.
30. Kiriluk, K. J., Prasad, S. M., Patel, A. R., Steinberg, G. D., and Smith, N. D. (2012). Bladder cancer risk from occupational and environmental exposures. Urol. Oncol. 30, 199-211. doi: 10.1016/j.urolonc.2011.10.010.
31. Knowles, M. A. (2006). Molecular subtypes of bladder cancer: jekyll and hyde or chalk and cheese. Carcinogenesis 27, 361-373. doi: 10.1093/carcin/bgi310.
32. Knowles, M. A. (2008). Molecular pathogenesis of bladder cancer. Int. J. Clin. Oncol. 13, 287-297. doi: 10.1007/s10147-008-0812-0.
33. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S. L. (2009). Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25. doi: 10.1186/gb-2009-10-3-r25.
34. Lin, T., Dong, W., Huang, J., Pan, Q., Fan, X., Zhang, C., et al. (2009). MicroRNA-143 as a tumor suppressor for bladder cancer. J. Urol. 181, 1372-1380. doi: 10.1016/j.juro.2008.10.149.
35. Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Korner, H., et al. (2008). Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7, 2591-2600. doi: 10.4161/cc.7.16.6533.
36. Martin, J., Jenkins, R. H., Bennagi, R., Krupa, A., Phillips, A. O., Bowen, T., et al. (2011). Post-transcriptional regulation of transforming growth factor Beta-1 by microRNA-744. PLoS ONE 6:e25044. doi: 10.1371/journal.pone.0025044.
37. Neuzillet, Y., Paoletti, X., Ouerhani, S., Mongiat-Artus, P., Soliman, H., de The, H., et al. (2012). A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer. PLoS ONE 7:e48993. doi: 10.1371/journal.pone.0048993.
38. Pencina, M. J., D'Agostino, R. B. Sr., D'Agostino, R. B. Jr., and Vasan, R. S. (2008). Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 27, 157-172. discussion: 207-212. doi: 10.1002/sim.2929.
39. Qu, C., Liang, Z., Huang, J., Zhao, R., Su, C., Wang, S., et al. (2012). MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle 11, 785-796. doi: 10.4161/cc.11.4.19228.
40. Rosenfeld, N., Aharonov, R., Meiri, E., Rosenwald, S., Spector, Y., Zepeniuk, M., et al. (2008). MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol. 26, 462-469. doi: 10.1038/nbt1392.
41. Saito, Y., Friedman, J. M., Chihara, Y., Egger, G., Chuang, J. C., and Liang, G. (2009). Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem. Biophys. Res. Commun. 379, 726-731. doi: 10.1016/j.bbrc.2008.12.098.
42. Tao, J., Lu, Q., Wu, D., Li, P., Xu, B., Qing, W., et al. (2011). microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells. Oncol. Rep. 25, 1721-1729. doi: 10.3892/or.2011.1245.
43. Tellez, C. S., Juri, D. E., Do, K., Bernauer, A. M., Thomas, C. L., Damiani, L. A., et al. (2011). EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res. 71, 3087-3097. doi: 10.1158/0008-5472.CAN-10-3035.
44. Ueno, K., Hirata, H., Majid, S., Yamamura, S., Shahryari, V., Tabatabai, Z. L., et al. (2012). Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by downregulating RhoC and FZD4. Mol. Cancer Ther. 11, 244-253. doi: 10.1158/1535-7163.MCT-11-0592.
45. Van Roosbroeck, K., Pollet, J., and Calin, G. A. (2013). miRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Rev. Mol. Diagn. 13, 183-204. doi: 10.1586/erm.12.134.
46. Veerla, S., Lindgren, D., Kvist, A., Frigyesi, A., Staaf, J., Persson, H., et al. (2009). MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int. J. Cancer 124, 2236-2242. doi: 10.1002/ijc.24183.
47. Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjot, L., Ramanathan, R., Hansen, T. B., et al. (2011). Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int. J. Cancer 128, 1327-1334. doi: 10.1002/ijc.25461.
48. Yue, X., Wang, P., Xu, J., Zhu, Y., Sun, G., Pang, Q., et al. (2012). MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A. Oncol. Rep. 27, 1200-1206. doi: 10.3892/or.2011.1588.
49. Zabolotneva, A., Tkachev, V., Filatov, F., and Buzdin, A. (2010). How many antiviral small interfering RNAs may be encoded by the mammalian genomes. Biol. Direct. 5, 62. doi: 10.1186/1745-6150-5-62.
50. Zabolotneva, A. A., Zhavoronkov, A., Garazha, A. V., Roumiantsev, S. A., and Buzdin, A. A. (2012). Characteristic patterns of microRNA expression in human bladder cancer. Front. Genet. 3:310. doi: 10.3389/fgene.2012.00310.
51. Zhu, Y. Y., Machleder, E. M., Chenchik, A., Li, R., and Siebert, P. D. (2001). Reverse transcriptase template switching: a SMART approach for full-length cDNA library construction. Biotechniques 30, 892-897.